Medicare Enrolled
Dr. Brett Parra, M.D.
Urology Physician · Pensacola, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Parra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parra? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parra
Dr. Brett Parra is an urology physician in Pensacola, FL, with 20 years in practice. Based on federal Medicare data, Dr. Parra performed 26,103 Medicare services across 5,043 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parra received a total of $7,266 from 50 pharmaceutical and/or device companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 5% volume in FL$ $7,266 industry payments
Medicare Practice Summary
Medicare Utilization ↗26,103
Medicare services
Top 5% in FL for urology physician
5,043
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,305 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection | 11,690 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 5,175 | $0 | $3 |
| Identification of organisms by genetic analysis, amplified probe technique | 2,041 | $34 | $156 |
| Office visit, established patient (30-39 min) | 1,064 | $90 | $224 |
| Automated urinalysis | 936 | $2 | $16 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 513 | $69 | $364 |
| Injection, gadobenate dimeglumine (multihance), per ml | 450 | $1 | $16 |
| Office visit, established patient (20-29 min) | 364 | $66 | $148 |
| Yeast/candida DNA test | 342 | $34 | $123 |
| Infectious disease DNA/RNA test | 342 | $34 | $161 |
| Bladder ultrasound after voiding | 289 | $8 | $94 |
| Diagnostic exam of bladder and urethra using an endoscope | 287 | $180 | $664 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 171 | $34 | $177 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 171 | $34 | $149 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 171 | $34 | $149 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 171 | $34 | $123 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 171 | $34 | $123 |
| Complete ultrasound scan behind abdominal cavity | 170 | $73 | $361 |
| Ceftriaxone antibiotic injection | 160 | $0 | $36 |
| X-ray of abdomen, 1 view | 159 | $21 | $84 |
| New patient office visit (45-59 min) | 125 | $121 | $343 |
| Hospital follow-up visit, low complexity | 119 | $41 | $115 |
| Injection, triptorelin pamoate, 3.75 mg | 96 | $291 | $2,196 |
| Initial hospital admission, moderate complexity | 94 | $106 | $297 |
| Drug injection, under skin or into muscle | 81 | $11 | $93 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 67 | $41 | $2,932 |
| Blood creatinine level | 55 | $5 | $30 |
| Simple insertion of temporary bladder tube | 45 | $48 | $249 |
| Biopsy of prostate gland | 44 | $103 | $730 |
| Ultrasound scan of pelvic region through rectum | 44 | $26 | $418 |
| Mri scan of pelvis before and after contrast | 40 | $267 | $3,458 |
| Simple change of bladder tube | 39 | $66 | $367 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 38 | $26 | $141 |
| Office visit, established patient, complex (40-54 min) | 35 | $127 | $301 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 33 | $225 | $1,621 |
| Chest X-ray, 2 views | 31 | $24 | $96 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 28 | $581 | $2,644 |
| Ct scan of abdomen before and after contrast | 27 | $165 | $1,192 |
| New patient office visit (30-44 min) | 27 | $81 | $219 |
| Nuclear medicine study of bone and/or joint whole body | 26 | $167 | $628 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 26 | $46 | $93 |
| Ct scan of abdomen and pelvis without contrast | 23 | $150 | $892 |
| Ct scan of abdomen and pelvis before and after contrast | 21 | $260 | $1,776 |
| Insertion of stent in ureter using an endoscope | 19 | $102 | $1,986 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 19 | $327 | $1,272 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 18 | $169 | $3,774 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 12 | $280 | $898 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 12 | $199 | $1,120 |
| Shock wave crushing of kidney stones | 11 | $452 | $3,538 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 11 | $254 | $639 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
70.4% medium
29.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,266
Total received (2018-2024)
Avg $1,038/year across 7 years
Top 29% in FL for urology physician
50
Companies
349
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,782 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$384 (5.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$850
2023$1,276
2022$1,134
2021$1,207
2020$658
2019$1,111
2018$1,030
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$1,266
NeoTract Inc.
$589
ABBVIE INC.
$489
Janssen Biotech, Inc.
$461
PFIZER INC.
$460
Sumitomo Pharma America, Inc.
$367
Teleflex LLC
$329
PROCEPT BioRobotics Corporation
$298
Medtronic, Inc.
$291
COLOPLAST CORP
$255
Myovant Sciences Inc.
$197
Coloplast Corp
$190
180 Medical, Inc.
$183
Allergan, Inc.
$177
Allergan Inc.
$158
Medtronic USA, Inc.
$136
UROVANT SCIENCES INC
$120
Augmenix, Inc.
$100
Dendreon Pharmaceuticals LLC
$100
COMSORT, Inc
$100
Endo Pharmaceuticals Inc.
$96
AbbVie, Inc.
$91
AstraZeneca Pharmaceuticals LP
$81
UroGen Pharma, Inc.
$80
BLUEWIND MEDICAL
$60
Boston Scientific Corporation
$44
Blue Earth Diagnostics Limited
$42
Verity Pharmaceuticals Inc.
$42
Ferring Pharmaceuticals Inc.
$42
Merck Sharp & Dohme LLC
$38
Myriad Genetic Laboratories, Inc.
$32
Rochester Medical Corporation
$32
Bayer Healthcare Pharmaceuticals Inc.
$31
Sun Pharmaceutical Industries Inc.
$27
UROGEN PHARMA, INC.
$25
Travere Therapeutics, Inc.
$25
ROCHESTER MEDICAL CORPORATION
$23
Tempus AI, Inc
$21
Endo USA, Inc.
$21
AMAG Pharmaceuticals, Inc.
$16
Wilmington Medical Supply, Inc.
$16
Tolmar, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$15
Mission Pharmacal Company
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Amgen Inc.
$13
Avadel Specialty Pharmaceuticals, LLC
$12
Antares Pharma, Inc.
$12
Janssen Pharmaceuticals, Inc
$9
Clarus Therapeutics Inc.
$8
Top 3 companies account for 32.3% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANTAGE FIT · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axumin · BOTOX · BOTOX - UROLOGY · BOTOX THERAPEUTIC · CLEAN-CATH · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENTLECATH · GentleCath · INTERSTIM · INTRAROSA · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lumenis Pulse 120H · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · NURO · Noctiva · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · Prolaris · Prolia · REVI · REZUM · SpaceOAR · SpeediCath · TOVIAZ · Thiola · Trelstar · UROLIFT · Uribel · UroLift · UroLift System · VESICARE · XIAFLEX · XT CDX · XTANDI · XYOSTED · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $28 per 100 Medicare services performed
Geographic Context
Urology Physicians within 10 mi
19
Per 100K population
5.9
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Parra is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Parra experienced with testosterone injection?
Based on Medicare claims data, Dr. Parra performed 11,690 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parra receive payments from pharmaceutical companies?
Yes. Dr. Parra received a total of $7,266 from 50 companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parra's costs compare to other urology physicians in Pensacola?
Dr. Parra's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Pensacola
Browse urology physicians in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc..
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology